ME00556A - Freeze-dried pantoprazole preparation and pantoprazole injection - Google Patents

Freeze-dried pantoprazole preparation and pantoprazole injection

Info

Publication number
ME00556A
ME00556A MEP-696/08A MEP69608A ME00556A ME 00556 A ME00556 A ME 00556A ME P69608 A MEP69608 A ME P69608A ME 00556 A ME00556 A ME 00556A
Authority
ME
Montenegro
Prior art keywords
pantoprazole
preparation
injection
freeze
dried
Prior art date
Application number
MEP-696/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Rango Dietrich
Rudolf Linder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00556(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ME00556A publication Critical patent/ME00556A/xx
Publication of ME00556B publication Critical patent/ME00556B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
MEP-2008-696A 2000-11-22 2001-11-17 PENTOPRAZOL PREPARAT l PENTOPRAZOL INJEKCIJA OSUŠENI PUTEM ZAMRZAVANJA ME00556B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00125569 2000-11-22
YU37703A RS52024B (sr) 2000-11-22 2001-11-17 Pantoprazol preparat i pantoprazol injekcija osušeni putem zamrzavanja
PCT/EP2001/013296 WO2002041919A1 (en) 2000-11-22 2001-11-17 Freeze-dried pantoprazole preparation and pantoprazole injection

Publications (2)

Publication Number Publication Date
ME00556A true ME00556A (en) 2011-12-20
ME00556B ME00556B (me) 2011-12-20

Family

ID=8170452

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-696A ME00556B (me) 2000-11-22 2001-11-17 PENTOPRAZOL PREPARAT l PENTOPRAZOL INJEKCIJA OSUŠENI PUTEM ZAMRZAVANJA

Country Status (40)

Country Link
US (3) US6780881B2 (hu)
EP (2) EP1762249A3 (hu)
JP (1) JP4886158B2 (hu)
KR (2) KR100910606B1 (hu)
CN (1) CN1250292C (hu)
AR (2) AR034277A1 (hu)
AT (1) ATE381946T1 (hu)
AU (2) AU1604202A (hu)
BG (1) BG66329B1 (hu)
BR (1) BRPI0115483B8 (hu)
CA (2) CA2428870C (hu)
CY (1) CY1107896T1 (hu)
CZ (1) CZ304348B6 (hu)
DE (1) DE60132108T2 (hu)
DK (1) DK1339430T3 (hu)
EA (1) EA007602B1 (hu)
EC (1) ECSP034613A (hu)
EE (1) EE05236B1 (hu)
ES (1) ES2298295T3 (hu)
GE (1) GEP20053461B (hu)
HK (1) HK1060848A1 (hu)
HR (1) HRP20030410B1 (hu)
HU (1) HUP0303278A3 (hu)
IL (2) IL155601A0 (hu)
IS (1) IS2971B (hu)
ME (1) ME00556B (hu)
MX (1) MXPA03004548A (hu)
MY (1) MY137726A (hu)
NO (1) NO332937B1 (hu)
NZ (1) NZ525911A (hu)
PE (1) PE20020582A1 (hu)
PL (1) PL201188B1 (hu)
PT (1) PT1339430E (hu)
RS (1) RS52024B (hu)
SI (1) SI1339430T1 (hu)
SK (1) SK287993B6 (hu)
TW (1) TWI284041B (hu)
UA (1) UA80961C2 (hu)
WO (1) WO2002041919A1 (hu)
ZA (1) ZA200303593B (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20050287231A1 (en) * 2002-06-21 2005-12-29 Nussen Kenneth H Method and apparatus for oral hygiene products with green tea extract
EP1562546A1 (en) * 2002-10-25 2005-08-17 Pfizer Products Inc. Depot formulations of arylheterocyclic active agents in the form of a suspension
WO2004099183A1 (en) * 2003-05-06 2004-11-18 Hetero Drugs Limited Novel polymorphs of pantoprazole sodium
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
US20050004172A1 (en) * 2003-05-19 2005-01-06 Pliva-Istrazivacki Institut D.O.O. Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes
AR045258A1 (es) 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
WO2005070426A1 (en) * 2004-01-27 2005-08-04 Altana Pharma Ag Freeze-dried (-)-pantoprazole preparation and (-)-pantoprazole injection
DE102004007854A1 (de) * 2004-02-17 2005-09-01 Hexal Ag Stabile, wässrige Formulierung für Benzimidazole
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
CN1293879C (zh) * 2005-01-20 2007-01-10 杭州华东医药集团生物工程研究所有限公司 泮托拉唑钠冻干粉针剂及其制备方法
AU2006299424A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties
AR061155A1 (es) * 2006-06-01 2008-08-06 Combino Pharm Sl Preparaciones liofilizadas de pantoprazol sodico para inyeccion
SI2049142T2 (sl) 2006-07-26 2016-04-29 Sandoz Ag Formulacije kaspofungina
US7979200B2 (en) * 2006-11-20 2011-07-12 Lockheed Martin Corporation Managing an air-ground communications network with air traffic control information
EP2106788A1 (en) * 2008-04-04 2009-10-07 Ipsen Pharma Liquid and freeze dried formulations
CN101744777B (zh) * 2009-12-30 2012-09-26 北京四环科宝制药有限公司 奥美拉唑钠冻干粉针剂及制备方法和检测方法
CN101961309B (zh) * 2010-09-15 2012-06-27 河南辅仁怀庆堂制药有限公司 注射用泮托拉唑钠配制工艺
CN102000034B (zh) * 2010-10-13 2011-12-21 江苏奥赛康药业股份有限公司 一种供注射用的s-泮托拉唑钠组合物及其制备方法
CN102225063B (zh) * 2011-05-10 2012-10-10 江苏奥赛康药业股份有限公司 一种供注射用的泮托拉唑钠组合物
TR201108946A2 (tr) * 2011-09-12 2012-04-24 World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.
CN104582687A (zh) * 2012-06-27 2015-04-29 武田药品工业株式会社 用盐稳定的胺和有机酸的液体制剂
CN104000786A (zh) * 2013-02-25 2014-08-27 杭州赛利药物研究所有限公司 泮托拉唑钠冻干制剂及其制备方法
CN104414979A (zh) * 2013-08-21 2015-03-18 哈药集团三精制药股份有限公司 一种泮托拉唑钠冻干粉针剂及其制备方法
CN104019635B (zh) * 2014-06-19 2015-05-27 上海慈瑞医药科技有限公司 一种兰索拉唑原料药化合物及其干燥工艺
CN104055791A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗眼角结膜炎的用途
CN104055792A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗中耳炎的用途
BE1021311B1 (nl) * 2014-07-31 2015-10-28 Neogen N.V. Werkwijze voor het maken van een poedervormige protonpompremmer samenstelling, genoemde samenstelling en gebruik
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN111643460A (zh) * 2020-06-30 2020-09-11 武汉九州钰民医药科技有限公司 泮托拉唑钠冻干制剂及其制备方法、由其制得的注射制剂
CN112274481A (zh) * 2020-10-27 2021-01-29 海南卫康制药(潜山)有限公司 一种注射用泮托拉唑钠组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US5223515A (en) 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
DE69305642T2 (de) 1992-07-28 1997-02-27 Astra Ab, Soedertaelje Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten
WO1994024867A1 (en) 1993-04-27 1994-11-10 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
DE4324014C2 (de) * 1993-07-17 1995-06-08 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
TW280770B (hu) 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
FR2740686B1 (fr) 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
HU224987B1 (en) 1995-11-03 2006-05-29 Sanofi Aventis Stable freeze-dried pharmaceutical formulation
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
EP1039905B1 (en) 1997-10-14 2006-07-05 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
WO2000026185A2 (en) 1998-10-30 2000-05-11 The Curators Of The University Of Missouri Omeprazole solution and method of using same
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1235018A (zh) * 1999-04-22 1999-11-17 沈阳东宇药业有限公司 泮托拉唑钠冻干粉针剂及制备方法
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
WO2002015908A1 (fr) * 2000-08-18 2002-02-28 Takeda Chemical Industries, Ltd. Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
AR045258A1 (es) 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion

Also Published As

Publication number Publication date
AU2002216042B2 (en) 2006-08-03
PL201188B1 (pl) 2009-03-31
UA80961C2 (en) 2007-11-26
CA2541946A1 (en) 2002-05-30
PT1339430E (pt) 2008-03-27
CZ20031416A3 (cs) 2003-09-17
BG66329B1 (bg) 2013-06-28
EA007602B1 (ru) 2006-12-29
EE05236B1 (et) 2009-12-15
CN1476335A (zh) 2004-02-18
TWI284041B (en) 2007-07-21
IL155601A (en) 2008-12-29
IS6820A (is) 2003-05-19
JP4886158B2 (ja) 2012-02-29
YU37703A (sh) 2006-05-25
IS2971B (is) 2017-05-15
HRP20030410B1 (en) 2011-02-28
NO20032303L (no) 2003-05-21
HUP0303278A2 (hu) 2004-01-28
ES2298295T3 (es) 2008-05-16
ATE381946T1 (de) 2008-01-15
AR034277A1 (es) 2004-02-18
US20030003058A1 (en) 2003-01-02
AU1604202A (en) 2002-06-03
CA2428870C (en) 2006-05-23
HK1060848A1 (en) 2004-08-27
MXPA03004548A (es) 2003-09-10
IL155601A0 (en) 2003-11-23
NO332937B1 (no) 2013-02-04
WO2002041919A1 (en) 2002-05-30
BR0115483A (pt) 2003-10-21
PL361118A1 (en) 2004-09-20
EE200300182A (et) 2003-06-16
MY137726A (en) 2009-03-31
US20090093522A1 (en) 2009-04-09
EP1762249A2 (en) 2007-03-14
ECSP034613A (es) 2003-08-29
US8754108B2 (en) 2014-06-17
ZA200303593B (en) 2004-04-23
JP2004513970A (ja) 2004-05-13
CA2428870A1 (en) 2002-05-30
PE20020582A1 (es) 2002-07-06
NZ525911A (en) 2004-11-26
CZ304348B6 (cs) 2014-03-19
RS52024B (sr) 2012-04-30
SK6062003A3 (en) 2003-10-07
CN1250292C (zh) 2006-04-12
ME00556B (me) 2011-12-20
KR20080003010A (ko) 2008-01-04
SK287993B6 (sk) 2012-09-03
CY1107896T1 (el) 2013-09-04
US7351723B2 (en) 2008-04-01
EP1339430A1 (en) 2003-09-03
GEP20053461B (en) 2005-02-25
US20040220228A1 (en) 2004-11-04
KR100910606B1 (ko) 2009-08-04
KR100910607B1 (ko) 2009-08-04
HRP20030410A2 (en) 2005-04-30
KR20030055308A (ko) 2003-07-02
SI1339430T1 (sl) 2008-06-30
HUP0303278A3 (en) 2007-08-28
DE60132108T2 (de) 2008-12-11
DK1339430T3 (da) 2008-05-13
BG107828A (bg) 2004-07-30
EA200300501A1 (ru) 2003-12-25
BRPI0115483B8 (pt) 2021-05-25
AR092374A2 (es) 2015-04-15
EP1762249A3 (en) 2014-05-14
US6780881B2 (en) 2004-08-24
EP1339430B1 (en) 2007-12-26
BRPI0115483B1 (pt) 2017-05-09
NO20032303D0 (no) 2003-05-21
DE60132108D1 (de) 2008-02-07

Similar Documents

Publication Publication Date Title
ME00556A (en) Freeze-dried pantoprazole preparation and pantoprazole injection
BR0016879A (pt) Métodos para transferência de interleucina-2 por via pulmonar
HU229368B1 (en) Novel vaccine composition
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
ATE330585T2 (de) Behandlung von atemerkrankungen
US10383852B2 (en) Prevention and treatment of viral infections
WO2010139808A3 (en) Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections
US11590099B2 (en) Prevention and treatment of viral infections
JPH06502413A (ja) 抗ウイルス活性をもつプロアントシアニジンポリマーおよびその製造法
KR20090005963A (ko) 보툴리눔 독소의 안정성이 개선된 약제학적 액상 조성물
SI2198007T1 (en) Pharmaceutical compositions containing Clostridium difficile A and B toxoids
BR9712970A (pt) Método para produção de vacina para proteção contra virus sincitial respiratório, mistura de proteìna de fusão purificada, composição imunogênica
DE60126947D1 (de) Behandlung der glykogenspeicherkrankheit typ ii
CN111701015A (zh) 可防治新冠病毒感染等呼吸系统疾病和其他疾病的组合物
CN114224771A (zh) 一种免洗洗手液及其制备方法
DE602005019672D1 (de) Getrocknetes Extrakt aus mit Vaccinia-Viren geimpfter, entzündeter Kaninchenhaut und Prozess zur Herstellung
WO2010087771A8 (en) Compound and method for treatment of alzheimer's disease
BR0107827A (pt) Atenuação recombinante de prrsv
KR101976560B1 (ko) 건조 추출물들을 생산하는 방법
KR102353119B1 (ko) 시아노박테리아 추출물, 이의 제조 방법 및 그 용도
US12011429B2 (en) Prevention and treatment of viral infections
WO2001094386A3 (de) Verfahren zur gewinnung und anwendung von antibiotisch wirksamen peptiden zur behandlung von infektionskrankheiten
US20210402001A1 (en) Zinc Porters, and their Monoclonal Antibody Conjugates, for the Prevention and Treatment of COVID-19 (SARS-CoV-2), Other Infections, and Cancers
JPWO2017110767A1 (ja) 抗ノロウイルス組成物及びその利用
Vilhelmova-Ilieva et al. Antiviral Potential of Specially Selected Bulgarian Propolis Ex-Tracts: In Vitro Mechanism of Action Against Structurally Differ-Ent Viruses